This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 24/1/141    most recent 01.ATV.0000107027.73816.cev1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rizzo, M. Articles by Krauss, R. M. Search for Related Content PubMed PubMed Citation Articles by Rizzo, M. Articles by Krauss, R. M. Related Collections Pathophysiology Risk Factors Genetics of cardiovascular disease Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:141.)
© 2004 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits

Manfredi Rizzo; John M. Taylor; Carlo M. Barbagallo; Kaspar Berneis; Patricia J. Blanche; Ronald M. Krauss

From the Department of Genome Sciences (M.R., P.J.B., R.M.K.), Lawrence Berkeley National Laboratory, University of California, Berkeley; the Department of Clinical Medicine and Emerging Diseases (M.R., C.M.B.), University of Palermo, Italy; the Gladstone Institute of Cardiovascular Disease (J.M.T.), University of California, San Francisco; and the Department of Internal Medicine (K.B.), University Hospital Bruderholz, Switzerland.

Correspondence to Ronald M. Krauss, MD, Children’s Hospital Oakland Research Institute (CHORI), 5700 Martin Luther King, Jr. Way, Oakland, CA 94609-1673. E-mail rmkrauss{at}lbl.gov

Objective— The effects of combined expression of human hepatic lipase (HL) and human apolipoprotein B (apoB) on low-density lipoprotein (LDL) subclasses were examined in rabbits, a species naturally deficient in HL activity.

Methods and Results— In apoB-transgenic rabbit plasma, >80% of the protein was found in the 1.006- to 1.050-g/mL fraction. Gradient gel electrophoresis (GGE) of this fraction revealed two distinct species, designated large and small LDL. A denser fraction (d=1.050 to 1.063 g/mL) contained small LDL as well as another discrete LDL subspecies, designated very small LDL. Expression of HL resulted in reductions in protein concentrations in the 1.006- to 1.050-g/mL density-gradient subfractions containing large (6.5±4.1 versus 32.6±12.0 mg/dL, P<0.005) and small LDL (59.6±17.4 versus 204.3±50.3 mg/dL, P<0.002). A concomitant small but not significant increase in protein concentration in the denser LDL fraction (48.0±28.2 versus 44.6±18.2 mg/dL) was due primarily to an increase in very small LDL (25.9±3.1 versus 9.6±5.4% of total LDL GGE densitometric area, P<0.002).

Conclusion— These findings support a direct role for HL in regulating total plasma LDL concentrations as well as in the production of smaller, denser LDL from larger, more buoyant precursors.

Key Words: hepatic lipase • apoB • LDL • transgene • rabbit • density gradient ultracentrifugation

This article has been cited by other articles:

				M. Rizzo, R. Trepp, K. Berneis, and E. R Christ Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy Eur. J. Endocrinol., March 1, 2007; 156(3): 361 - 367. [Abstract] [Full Text] [PDF]

				L. Freeman, M. J. A. Amar, R. Shamburek, B. Paigen, H. B. Brewer Jr., S. Santamarina-Fojo, and H. Gonzalez-Navarro Lipolytic and ligand-binding functions of hepatic lipase protect against atherosclerosis in LDL receptor-deficient mice J. Lipid Res., January 1, 2007; 48(1): 104 - 113. [Abstract] [Full Text] [PDF]

				K. Berneis, M. Rizzo, V. Lazzaroni, F. Fruzzetti, and E. Carmina Atherogenic Lipoprotein Phenotype and Low-Density Lipoproteins Size and Subclasses in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 186 - 189. [Abstract] [Full Text] [PDF]

				M. Rizzo and K. Berneis Low-density lipoprotein size and cardiovascular risk assessment QJM, January 1, 2006; 99(1): 1 - 14. [Abstract] [Full Text] [PDF]

				R. M. Krauss Dietary and Genetic Probes of Atherogenic Dyslipidemia Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2265 - 2272. [Abstract] [Full Text] [PDF]

				H. Gonzalez-Navarro, Z. Nong, M. J. A. Amar, R. D. Shamburek, J. Najib-Fruchart, B. J. Paigen, H. B. Brewer Jr., and S. Santamarina-Fojo The Ligand-binding Function of Hepatic Lipase Modulates the Development of Atherosclerosis in Transgenic Mice J. Biol. Chem., October 29, 2004; 279(44): 45312 - 45321. [Abstract] [Full Text] [PDF]

				S. Santamarina-Fojo, H. Gonzalez-Navarro, L. Freeman, E. Wagner, and Z. Nong Hepatic Lipase, Lipoprotein Metabolism, and Atherogenesis Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1750 - 1754. [Abstract] [Full Text] [PDF]

				H. L. Dichek, K. Qian, and N. Agrawal Divergent Effects of the Catalytic and Bridging Functions of Hepatic Lipase on Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1696 - 1702. [Abstract] [Full Text] [PDF]